Bio-Medisinsk Innovasjon AS
This article was originally published in Start Up
Executive Summary
Failing hearts are able to bind more serotonin than normal hearts, which prompted the founders of Bio-Medisinsk Innovasjon to look for heart failure treatments in agents capable of inhibiting serotonin.